Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Proactive Video

<< Previous

Bullboard Posts

Next >>

Comment by Tarbabyon Sep 03, 2024 8:11pm

174 Views

Post# 36207179

RE:New Proactive Video

Have they actually studied Ruvidar for HSV treatment in small animals or only on cells infected with the virus in vitro?
Then from animals to humans is a big step.
More details are needed to convince investors. In other words...show it... dont just say it. I truly hope its all real both for us investors and the public good.

<< Previous

Bullboard Posts

Next >>

How to navigate the ups and downs of investing in AI